Earnings Feed
Start Free
Home/Filings/4/0001209191-15-073815
4//SEC Filing

MERRIMACK PHARMACEUTICALS INC 4

Accession 0001209191-15-073815

CIK 0001274792operating
View on SEC.govCompany Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:11 PM ET

Size

13.8 KB

Accession

0001209191-15-073815

Insider Transaction Report

Form 4
Period: 2015-10-01
MERRIMACK PHARMACEUTICALS INCMACK
Stewart Edward J.
SVP & Pres, Healthcare Sol
Transactions
  • Exercise/Conversion

    Common Stock

    2015-10-01$1.81/sh+4,000$7,240→ 25,385 total
  • Exercise/Conversion

    Common Stock

    2015-10-02$1.81/sh+1,000$1,810→ 22,385 total
  • Sale

    Common Stock

    2015-10-02$9.00/sh−1,000$9,000→ 21,385 total
  • Sale

    Common Stock

    2015-10-01$8.00/sh−4,000$32,000→ 21,385 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2015-10-01−4,000→ 25,000 total
    Exercise: $1.81Exp: 2018-09-22→ Common Stock (4,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2015-10-02−1,000→ 24,000 total
    Exercise: $1.81Exp: 2018-09-22→ Common Stock (1,000 underlying)
Footnotes (2)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]This option is fully vested.

Documents

1 file

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001274792

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:11 PM ET
Size
13.8 KB
View on SEC.gov